WAY 📈 Waystar Holding Common Stock - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock •
WAY: Cloud, Software, Healthcare, Payments, Financial, Analytics
Waystar Holding Corp. is a technology-driven company that has developed a comprehensive cloud-based software solution designed to streamline healthcare payments. By leveraging its platform, healthcare providers can efficiently manage financial clearance, patient financial care, and claim and payment management, thereby reducing administrative burdens and minimizing revenue loss. The platform also incorporates advanced denial prevention and recovery capabilities, enabling healthcare providers to optimize revenue capture and reduce bad debt. Furthermore, the platform provides analytics and reporting solutions, allowing healthcare providers to gain valuable insights into their financial performance and make data-driven decisions.
The company's primary focus is on serving the healthcare industry, where it has established itself as a leading provider of innovative payment solutions. With its headquarters in Lehi, Utah, Waystar Holding Corp. has been in operation since 2017, and has since then been committed to delivering cutting-edge technology solutions that cater to the evolving needs of the healthcare sector. For more information about the company and its offerings, one can visit their website at https://waystar.com. As a publicly traded company, Waystar Holding Corp.'s common stock is listed on the NASDAQ stock exchange under the ticker symbol WAY, and is classified under the Health Care Technology sub-industry, which falls within the broader GICS sector.
From a technological standpoint, Waystar Holding Corp.'s cloud-based platform is designed to be highly scalable, secure, and interoperable, allowing it to seamlessly integrate with existing healthcare systems and workflows. This enables healthcare providers to automate manual processes, reduce errors, and improve patient satisfaction, while also enhancing their overall financial performance. By providing a comprehensive suite of payment solutions, Waystar Holding Corp. is well-positioned to capitalize on the growing demand for digital transformation in the healthcare industry, and to drive long-term growth and profitability for its shareholders.
Additional Sources for WAY Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
WAY Stock Overview
Market Cap in USD | 4,475m |
Sector | Healthcare |
Industry | Health Information Services |
GiC Sub-Industry | Health Care Technology |
IPO / Inception | 2024-06-07 |
WAY Stock Ratings
Growth 5y | 73.0% |
Fundamental | 19.0% |
Dividend | - |
Rel. Strength Industry | 1249 |
Analysts | 4.56/5 |
Fair Price Momentum | 40.77 USD |
Fair Price DCF | 13.91 USD |
WAY Dividends
No Dividends PaidWAY Growth Ratios
Growth Correlation 3m | 89% |
Growth Correlation 12m | 96.8% |
Growth Correlation 5y | 96.8% |
CAGR 5y | 77.87% |
CAGR/Mean DD 5y | 35.06 |
Sharpe Ratio 12m | 2.33 |
Alpha | 63.62 |
Beta | 0.45 |
Volatility | 31.48% |
Current Volume | 2642.5k |
Average Volume 20d | 1550.6k |
As of December 22, 2024, the stock is trading at USD 36.82 with a total of 2,642,500 shares traded.
Over the past week, the price has changed by +3.80%, over one month by +13.64%, over three months by +31.40% and over the past year by +71.45%.
Neither. Based on ValueRay Fundamental Analyses, Waystar Holding Common Stock is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 18.99 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of WAY as of December 2024 is 40.77. This means that WAY is currently undervalued and has a potential upside of +10.73% (Margin of Safety).
Waystar Holding Common Stock has received a consensus analysts rating of 4.56. Therefor, it is recommend to buy WAY.
- Strong Buy: 5
- Buy: 4
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, WAY Waystar Holding Common Stock will be worth about 44.3 in December 2025. The stock is currently trading at 36.82. This means that the stock has a potential upside of +20.4%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 30.3 | -17.8% |
Analysts Target Price | 30.3 | -17.8% |
ValueRay Target Price | 44.3 | 20.4% |